本頁面由Tiger Trade Technology Pte. Ltd.提供服務

福泰製藥

553.19
+5.601.02%
成交量:35.51萬
成交額:1.96億
市值:1,403.53億
市盈率:32.20
高:555.69
開:545.53
低:543.75
收:547.59
52周最高:555.69
52周最低:374.17
股本:2.54億
流通股本:2.54億
量比:0.34
換手率:0.14%
股息:- -
股息率:- -
每股收益(TTM):17.18
每股收益(LYR):15.32
淨資產收益率:23.54%
總資產收益率:11.93%
市淨率:6.93
市盈率(LYR):36.11

資料載入中...

2026/05/14

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/14

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/14

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/13

重要事件披露

Form 8-K - Current report
2026/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/05/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/02

SEC問詢函

Form CORRESP - Correspondence
2026/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/31

重要事件披露

Form 8-K - Current report
2026/03/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities